New approaches in the diagnosis of tuberculous infection
DOI:
https://doi.org/10.52692/1857-0011.2024.2-79.48Keywords:
Tuberculosis infection, Tuberculin skin test, IGRA, TBST, Mycobacterium tuberculosisAbstract
This article explores the importance of implementing new skin tests based on specific Mycobacterium tuberculosis antigens (TBST) in diagnosing tuberculosis infection, emphasizing their specificity and applicability, especially among individuals vaccinated with the Bacillus Calmette-Guérin (BCG). TBST, which operates similarly to interferon - gamma release assays (IGRA), offers a more accurate alternative to traditional testing methods. The importance of this study lies in its contribution to improving strategies for preventing the progression of TB infection to active tuberculosis, a crucial aspect for reducing the incidence and mortality associated with tuberculosis, thereby supporting the objectives of the End TB strategy.
References
HG Nr. 107 din 23-02-2022 privind aprobarea Programului național de răspuns la tuberculoză pentru anii 2022-2025/Publicat: 04-03-2022 în Monitorul Oficial Nr. 61-67 art. 154/ https://www.legis.md/ cautare/getResults?doc_id=130171&lang=ro
Ordinul MS nr. 432 din 11.05.2022 „Cu privire la implementarea Programului National de răspuns la tuberculoza pentru anii 2022-2025”. https://simetb.ifp.md/Download/oficial_docs/Ordin_MS_2022_05_11_nr_432_implementare_PNCT .
Ordinul MS Nr.121 din 31/01/2024: Cu privire la aprobarea Protocolului clinic national “Tuberculoza la adult”, editia VI si Protocolul cilnic national “Tuberculoza la adult”, editia VI.
Ordinul MS Nr. 481 din 31/05/2023:Cu privire la aprobarea Ghidului “Organizarea si desfasurarea screening-ului sistematic si a tratamentului preventiv al tuberculozei” si ghidul “Organizarea si desfasurarea screening-ului sistematic si a tratamentului preventiv al tuberculozei”.
World Health Organization. (2011). Recommendations for the use of interferon-gamma release assays (IGRAs) in diagnosing TB infection. WHO Press.
World Health Organization. (2018). Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management. Geneva: WHO.
World Health Organization. (2023). Global tuberculosis report. Geneva: WHO.
World Health Organization. (2022). Systematic review on new TB screening tests (TBST) accuracy and safety. Geneva: WHO.
World Health Organization. (2022). TB prevention: A guide for programmatic implementation of preventive treatment. Geneva: WHO.
World Health Organization. (2024). Consolidated clinical guidelines on TB diagnosis and treatment. Geneva: WHO.
Sester, M., Sotgiu, G., Lange, C., et al. (2021). Interferon-gamma release assays for the diagnosis of TB infection. The Lancet Infectious Diseases, 21(2), e77-e87.
Nahid, P., Dorman, S. E., Alipanah, N., et al. (2016). Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical Infectious Diseases, 63(7), e147-e195.
Lawn, S. D., & Zumla, A. I. (2011). Tuberculosis. The Lancet, 378(9785), 57-72.
Rapid communication: TB antigen-based skin tests for the diagnosis of TB infection. TB antigen-based skin tests for the diagnosis of TB infection, 4 April 2022, https://www.who.int/publications/i/item/WHO-UCN-TB-2022.1.
Downloads
Published
License
Copyright (c) 2025 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
